CNTA vs PKI
Centessa Pharmaceuticals PLC ADR (CNTA) versus PKI (PKI) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
PKI (PKI) common stock.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
PKI does not have a complete income-statement cache yet.
CNTA currently screens at market cap $6.15B.
Not investment advice. Open the CNTA and PKI stock pages for the full models.
Not investment advice.